Population
Recombinant form of Foot-and-Mouth Disease Virus (FMDV) 3C protease
Design
Preclinical
Authors
Loading...
Provides framework for FMDV 3Cpro inhibitor design; leaves open efficacy in cellular or animal models.
The determination of the FMDV 3C protease crystal structure and its cleavage specificity provides a structural framework for developing targeted antiviral inhibitors.
Birtley et al. (2005) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: